Frazier Life Sciences Management »

Silence Therapeutics shares owned by Frazier Life Sciences Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Frazier Life Sciences Management from 13F filings

Historical chart of Frazier Life Sciences Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Frazier Life Sciences Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 881k 17.37
2023-09-30 $8.7M 881k 9.83
2023-06-30 $4.8M 881k 5.50
2023-03-31 $5.5M 881k 6.20
2022-12-31 $13M 881k 15.25
2022-09-30 $8.7M 881k 9.87
2022-06-30 $10M 881k 11.85
2022-03-31 $17M 881k 19.00